Latest Strategy News

Findi Limited’s Indian arm has locked in a A$72 million strategic investment from Nova Global, setting the stage for rapid growth in ATM deployments and digital payments. Alongside this, the company has refreshed its board with seasoned financial services experts to steer its next phase.

Nova Eye Medical has reported a record US$6.1 million in sales for the December 2025 quarter, driven by strong US demand and a 24% annual growth rate that outpaces the industry.

StepChange Holdings has completed its acquisition of Perth-based ICT advisory firm BroadReach, significantly boosting its digital transformation and government consulting capabilities.

TG Metals Limited has reported strong new drilling results from its Van Uden Gold Project, revealing high-grade gold intercepts and promising extensions to its existing resource. The company is advancing plans for further drilling and resource updates in early 2026.

Midas Minerals has reported a significant new high-grade copper and silver find at its Spaatzu Prospect within Namibia’s Otavi Copper Project, marking a promising expansion near the established T-13 deposit.

Firebird Metals has commissioned its proprietary equipment for producing advanced lithium-manganese-rich cathode materials at its China pilot plant, aiming to start production in February 2026 with customer samples planned for later in the year. The project is co-funded by strategic partner Taza Metal Technologies, reducing capital risk and accelerating development.

Tamboran Resources has appointed Todd Abbott as CEO, bringing over 25 years of upstream oil and gas expertise to lead its pivotal Beetaloo Basin development.

Eden Innovations has secured a $2.2 million strategic investment to fully repay its remaining iBorrow debt, eliminating costly interest payments and strengthening its balance sheet ahead of anticipated revenue growth.

ReNerve Limited has secured broader regulatory approval in Hong Kong for its NervAlign® Nerve Cuff, enabling access to both public and private hospitals and validating the device’s clinical benefits through independent review.

QMines Limited’s maiden drilling program at Mount Mackenzie delivers consistent high-grade gold and silver results, confirming multiple mineralised zones with promising depth extensions. The company advances towards an updated Pre-Feasibility Study, underpinning future mine design and resource growth.

Legacy Minerals has initiated a 2,000-metre diamond drilling program at the Mascotte Silver-Gold Prospect, aiming to grow its substantial 115Moz silver-equivalent resource at Mt Carrington. This move follows promising historical data and recent rock chip assays confirming high-grade gold and silver mineralisation.

Clinuvel Pharmaceuticals has initiated dosing in a preclinical study of its novel controlled-release injectable peptide platform, VLRX-L, aiming to enhance drug delivery for melanocortin-based therapies. Preliminary results are expected in the second half of 2026.